0001209191-23-023588.txt : 20230406
0001209191-23-023588.hdr.sgml : 20230406
20230406162335
ACCESSION NUMBER: 0001209191-23-023588
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230404
FILED AS OF DATE: 20230406
DATE AS OF CHANGE: 20230406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanna Bastiano
CENTRAL INDEX KEY: 0001829069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23806481
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-04
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001829069
Sanna Bastiano
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Cell & Genetic Therapies
1
Common Stock
2023-04-04
4
S
0
211
314.22
D
47591
D
Common Stock
2023-04-04
4
S
0
94
315.66
D
47497
D
Common Stock
2023-04-04
4
S
0
90
316.76
D
47407
D
Common Stock
2023-04-04
4
S
0
96
317.65
D
47311
D
Common Stock
2023-04-04
4
S
0
31
318.68
D
47280
D
Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1, which was entered into on 08/10/2022.
Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $314.22 (range $313.72 to $314.70).
Open market sales reported on this line occurred at a weighted average price of $315.66 (range $315.08 to $315.96).
Open market sales reported on this line occurred at a weighted average price of $316.76 (range $316.41 to $317.20).
Open market sales reported on this line occurred at a weighted average price of $317.65 (range $317.49 to $317.74).
/s/ Christiana Stevenson, Attorney-in-Fact
2023-04-06